AMPK Methods and Protocols

(Rick Simeone) #1
purified AMPK can be eluted from anti-FLAG M2 affinity
agarose gel using FLAG elution buffer instead of glutathione
agarose elution buffer. Note that CaMKK2 phosphorylation
cannot be performed on anti-FLAG M2 affinity agarose gel
because FLAG peptide present in CaMKK2 preparations gen-
erated by our method will result in undesirable AMPK elution
during the phosphorylation step.


  1. Both β1 (30.4 kDa) and γ3 (54.3 kDa) subunits display
    reduced electrophoretic mobility on SDS-PAGE, relative to
    expected mobility based on molecular mass.

  2. A second elution step can be performed. The second elution
    typically possesses half the protein concentration of the first
    with similar volume.

  3. Yields can vary significantly between preparations, being influ-
    enced mainly by cell viability, transfection efficiency, and the
    recombinant AMPK complex being expressed. Typically, we
    achieve yields of 1–2μg purified AMPK per 10 cm dish.

  4. Nonreducing lysis buffer (devoid of DTT or reducing agent
    equivalents) is necessary to avoid dissociation of the heavy and
    light chains in the immobilized M2 antibody present on anti-
    FLAG M2 affinity agarose gel. This consideration is important
    for maximal yield.


References



  1. Oakhill JS, Scott JW, Kemp BE (2012) AMPK
    functions as an adenylate charge-regulated pro-
    tein kinase. Trends Endocrinol Metab
    23:125–132

  2. Jeon S-M (2016) Regulation and function of
    AMPK in physiology and diseases. Exp Mol
    Med 48:e245

  3. Ferrer A, Caelles C, Massot N et al (1985)
    Activation of rat liver cytosolic 3-hydroxy-3-
    methylglutaryl coenzyme a reductase kinase
    by adenosine 5^0 -monophosphate. Biochem
    Biophys Res Comm 132:497–504

  4. Hawley SA, Davison M, Woods A et al (1996)
    Characterization of the AMP-activated protein
    kinase kinase from rat liver and identification of
    threonine 172 as the major site at which it
    phosphorylates AMP-activated protein kinase.
    J Biol Chem 271:27879–27887

  5. Neumann D, Woods A, Carling D et al (2003)
    Mammalian AMP-activated protein kinase:
    functional, heterotrimeric complexes by
    co-expression of subunits inEscherichia coli.
    Protein Expr Purif 30:230–237

  6. Iseli TJ, Oakhill JS, Bailey MF et al (2008)
    AMP-activated protein kinase subunit interac-
    tions: beta1:gamma1 association requires


beta1 Thr-263 and Tyr-267. J Biol Chem
283:4799–4807


  1. Scott JW, van Denderen BJ, Jorgensen SB et al
    (2008) Thienopyridone drugs are selective
    activators of AMP-activated protein kinase
    beta1-containing complexes. Chem Biol
    15:1220–1230

  2. Oakhill JS, Chen ZP, Scott JW et al (2010)
    β-subunit myristoylation is the gatekeeper for
    initiating metabolic stress sensing by
    AMP-activated protein kinase (AMPK). Proc
    Natl Acad Sci U S A 107:19237–19241

  3. Bonthron DT, Handin RI, Kaufman RJ et al
    (1986) Structure of pre-pro-von Willebrand
    factor and its expression in heterologous cells.
    Nature 324:270–273

  4. Scott JW, Galic S, Graham KL et al (2015)
    Inhibition of AMP-activated protein kinase at
    the allosteric drug-binding site promotes islet
    insulin release. Chem Biol 22:705–711

  5. Scott JW, Ling N, Issa SM et al (2014) Small
    molecule drug A-769662 and AMP synergisti-
    cally activate naı ̈ve AMPK independent of
    upstream kinase signalling. Chem Biol
    21:619–627


Production in Mammalian Cells 169
Free download pdf